LAVA Therapeutics Stock Forward View
| LVTXDelisted Stock | USD 1.74 0.00 0.00% |
LAVA Stock outlook is based on your current time horizon.
The value of RSI of LAVA Therapeutics' stock price is slightly above 60. This indicates that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling LAVA, making its price go up or down. Momentum 60
Buy Extended
Oversold | Overbought |
Using LAVA Therapeutics hype-based prediction, you can estimate the value of LAVA Therapeutics NV from the perspective of LAVA Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of LAVA Therapeutics NV on the next trading day is expected to be 1.72 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.94. LAVA Therapeutics after-hype prediction price | USD 1.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
LAVA |
LAVA Therapeutics Additional Predictive Modules
Most predictive techniques to examine LAVA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for LAVA using various technical indicators. When you analyze LAVA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
LAVA Therapeutics Naive Prediction Price Forecast For the 31st of January
Given 90 days horizon, the Naive Prediction forecasted value of LAVA Therapeutics NV on the next trading day is expected to be 1.72 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.94.Please note that although there have been many attempts to predict LAVA Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that LAVA Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
LAVA Therapeutics Stock Forecast Pattern
| Backtest LAVA Therapeutics | LAVA Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of LAVA Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent LAVA Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.6312 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0318 |
| MAPE | Mean absolute percentage error | 0.02 |
| SAE | Sum of the absolute errors | 1.9381 |
Predictive Modules for LAVA Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LAVA Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LAVA Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LAVA Therapeutics After-Hype Price Density Analysis
As far as predicting the price of LAVA Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in LAVA Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of LAVA Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
LAVA Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting LAVA Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on LAVA Therapeutics' historical news coverage. LAVA Therapeutics' after-hype downside and upside margins for the prediction period are 0.09 and 4.19, respectively. We have considered LAVA Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
LAVA Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of LAVA Therapeutics is based on 3 months time horizon.
LAVA Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as LAVA Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LAVA Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with LAVA Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.36 | 2.48 | 0.03 | 0.00 | 27 Events / Month | 6 Events / Month | In about 27 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.74 | 1.71 | 1.72 |
|
LAVA Therapeutics Hype Timeline
LAVA Therapeutics is now traded for 1.74. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.0. LAVA is anticipated to decline in value after the next headline, with the price expected to drop to 1.71. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.72%, whereas the daily expected return is now at 0.36%. The volatility of related hype on LAVA Therapeutics is about 24800.0%, with the expected price after the next announcement by competition of 1.74. About 16.0% of the company outstanding shares are owned by corporate insiders. The book value of LAVA Therapeutics was now reported as 0.48. The company recorded a loss per share of 0.87. LAVA Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 27 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.LAVA Therapeutics Related Hype Analysis
Having access to credible news sources related to LAVA Therapeutics' direct competition is more important than ever and may enhance your ability to predict LAVA Therapeutics' future price movements. Getting to know how LAVA Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how LAVA Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CALC | CalciMedica Common Stock | 0.02 | 10 per month | 0.00 | (0.02) | 12.74 | (7.69) | 40.42 | |
| LTRN | Lantern Pharma | (0.13) | 8 per month | 0.00 | (0.09) | 8.59 | (5.57) | 23.91 | |
| ATNM | Actinium Pharmaceuticals | 0.01 | 8 per month | 0.00 | (0.11) | 5.84 | (5.43) | 20.75 | |
| TVRD | Tvardi Therapeutics | (0.11) | 7 per month | 0.00 | (0.11) | 5.59 | (5.80) | 17.33 | |
| XLO | Xilio Development | (0.01) | 10 per month | 0.00 | (0.14) | 4.69 | (5.56) | 15.41 | |
| PDSB | PDS Biotechnology Corp | 0.01 | 11 per month | 4.67 | (0) | 8.60 | (8.41) | 27.78 | |
| CELU | Celularity | 0.02 | 12 per month | 0.00 | (0.13) | 9.01 | (8.97) | 26.97 | |
| RVPH | Reviva Pharmaceuticals Holdings | 0.02 | 3 per month | 0.00 | (0.07) | 10.71 | (12.50) | 65.06 | |
| TPST | Tempest Therapeutics | 0.07 | 6 per month | 0.00 | (0.18) | 7.92 | (9.56) | 57.69 | |
| ELUT | Elutia Inc | 0.00 | 8 per month | 4.97 | 0.05 | 9.52 | (7.27) | 33.48 |
LAVA Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LAVA Therapeutics stock to make a market-neutral strategy. Peer analysis of LAVA Therapeutics could also be used in its relative valuation, which is a method of valuing LAVA Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
LAVA Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how LAVA Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading LAVA Therapeutics shares will generate the highest return on investment. By undertsting and applying LAVA Therapeutics stock market strength indicators, traders can identify LAVA Therapeutics NV entry and exit signals to maximize returns.
LAVA Therapeutics Risk Indicators
The analysis of LAVA Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in LAVA Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lava stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.33 | |||
| Semi Deviation | 1.19 | |||
| Standard Deviation | 2.25 | |||
| Variance | 5.06 | |||
| Downside Variance | 3.11 | |||
| Semi Variance | 1.42 | |||
| Expected Short fall | (2.29) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for LAVA Therapeutics
The number of cover stories for LAVA Therapeutics depends on current market conditions and LAVA Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that LAVA Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about LAVA Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
LAVA Therapeutics Short Properties
LAVA Therapeutics' future price predictability will typically decrease when LAVA Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of LAVA Therapeutics NV often depends not only on the future outlook of the potential LAVA Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LAVA Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.8 M | |
| Cash And Short Term Investments | 76.6 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in LAVA Stock
If you are still planning to invest in LAVA Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LAVA Therapeutics' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |